‘Science by press release’: Sudden rise of vaccine developer Moderna rankles some in scientific establishment
By Editor - Fri May 22, 6:44 am
Moderna Inc., a nearly 10-year-old Massachusetts-based biotech company, is suddenly the talk of the scientific community after they announced this week “positive” indications from their early work on a potential vaccine against the novel coronavirus. In April, Moderna received $483 million from the Biomedical Advanced Research and Development Authority (BARDA), the government agency charged with overseeing the rapid production of a vaccine.
See the rest here: